Jacobio Pharma to Present Data of Three Preclinical Studies at the 2023 AACR Annual Meeting ...Middle East

PR Newswire - News
Jacobio Pharma to Present Data of Three Preclinical Studies at the 2023 AACR Annual Meeting
BEIJING and SHANGHAI and BOSTON, Mass., March 14, 2023 /PRNewswire/ -- Jacobin Pharma (1167.HK) today announced that the company will present the results of three preclinical studies of KRASmulti inhibitor JAB-23425, CD73-STING iADC JAB-X1800, and Aurora kinase A inhibitor JAB-2485 in...

Hence then, the article about jacobio pharma to present data of three preclinical studies at the 2023 aacr annual meeting was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Jacobio Pharma to Present Data of Three Preclinical Studies at the 2023 AACR Annual Meeting )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News